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Abstract 
 
In the current study, Raman spectroscopy is employed for the identification of the biochemical 
changes taking place during the development of Hepatitis C. The Raman spectral data acquired 
from the human blood plasma samples of infected and healthy individuals is analysed by 
Principal Components Analysis and the Raman spectral markers of the Hepatitis C Virus (HCV) 
infection are identified. Spectral changes include those associated with nucleic acidsat720 cm-1, 
1077 cm-1 1678 (C=O stretching mode of dGTP of RNA), 1778 cm-1 (RNA), with proteins at 
1641 cm-1(amide-I), 1721 cm-1(C=C stretching of proteins) and lipids at 1738 cm-1(C=O of ester 
group in lipids). These differences in Raman spectral features of blood plasma samples of the 
patients and healthy volunteers can be associated with the development of the biochemical 
changes during HCV infection. 
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Introduction: 
Hepatitis C is caused by the infection of a virus and almost 3% of the world and 4.8 % Pakistani 
population is affected by this disease (Shepard, Finelli et al. 2005; Lavanchy 2009; Ford, Kirby 
et al. 2012). Currently available screening techniques, like Enzyme Linked Immunosorbent 
Assay (ELISA), involve the detection of the antibodies and pathogens in the blood of the patients 
infected by Hepatitis C virus (HCV) (Kesli, Polat et al. 2011). Although, ELISA is very 
commonly employed, observation of the false positive and false negative results indicates 
difficulties in blood screening (Gretch 1997; Martin, Fabrizi et al. 1998; Schiff, de Medina et al. 
1998).  
Polymerase Chain Reaction (PCR) is currently considered as the gold standard technique for the 
direct detection of the HCV RNA, the most reliable disease marker, in blood serum or plasma 
(Raeymaekers 1993; Pawlotsky 2003).To achieve accurate results from this method, the reagents 
and the instrumentation employed must be of high quality and sensitivity, respectively. In this 
regard, it is important to mention that PCR based methods are considered more reliable than 
ELISA based methods (Enomoto, Nishiguchi et al. 2001; Swellam, Mahmoud et al. 2011), but 
the former technique is time consuming, less commonly available, laborious and expensive. This 
demands the development of more reliable, rapid, biochemical label free and automated 
diagnosis method which may be helpful for effective disease management. 
Raman spectroscopy has been used for determining the biochemical changes in the bio-
macromolecules of cells and tissues, including lipids, proteins and DNA, simultaneously 
(Nawaz, Bonnier et al. 2010; Nawaz, Bonnier et al. 2011; Nawaz, Garcia et al. 2013). Moreover, 
the technique has been employed for the analysis of the body fluids, like blood plasma/serum and 
urine, for the diagnosis of the diseases (Neugebauer, Trenkmann et al. 2014; Pachaiappan, 
Prakasarao et al. 2017; Pappu, Prakasarao et al. 2017). The potential of Raman spectroscopy for 
the diagnosis of diseases which are caused by viral infections, such as dengue (Saleem, Bilal et 
al. 2013) and HPV (Ostrowska, Malkin et al. 2010; Ostrowska, Garcia et al. 2011)has also been 
demonstrated. 
Although the diagnosis of HCV infection in blood serum/plasma samples from infected patients 
by employing Raman spectroscopy has been reported, these studies used Principal Component 
Analysis (PCA) for the comparison of normal versus HCV positive samples (Saade, Pacheco et 
al. 2008) and a Partial Least Squares Regression (PLSR) model for the prediction of the viral 
load (Nawaz, Rashid et al. 2017). In the present study, serologically characterised HCV positive 
blood plasma samples are divided into three different groups, for the purpose of comparison, 
namely low, medium and high viral load samples, and their Raman spectral data is compared 
with that of control/healthy samples by using PCA of these three degrees of infection of disease. 
The analysis identifies specific spectral markers which may be associated with the presence, as 
well as degree of infection. 
Materials and methods 
Sample preparation 
Blood plasma samples from 10 healthy/control and 11 Hepatitis C patients with different viral 
load values, as described in Table 1, were collected from Allied Hospital, Faisalabad, Pakistan. 
These patients were diagnosed as infected with HCV by the Polymerase Chain Reaction (PCR) 
technique, and classified into three groups on the basis of viral load values, currently a gold 
standard for the diagnosis of Hepatitis, which quantified the HCV loads in the patient samples. 
Raman spectral acquisition 
A 20 μl drop of each plasma sample was placed on an aluminium slide at room temperature and 
Raman spectra were acquired before the plasma sample had dried. The process of placing the 
20μl drop on the aluminium slide was repeated 3 times by employing a clean aluminium slide 
each time for acquiring 20-25 spectra in total from each sample. 
Raman spectral acquisition from all of the 10 healthy/control and 11 HCV infected blood plasma 
samples was performed using a Raman spectrometer (Peak Seeker Pro-785; Agiltron, USA). The 
Peak Seeker Pro-785 utilizes a 785nm diode laser as the excitation source, delivering a laser 
power of ~60 mW at the sample. The laser was delivered to the sample through a 10× objective. 
The acquisition of the Raman spectra for all the samples was executed from 600 to 1800 cm-1and 
20–25 Raman spectra per sample were acquired with an acquisition time of 30 seconds. 
Data pre-processing 
All data processing of the Raman spectra was performed using MatLab 7.8 and established 
protocols (Nawaz, Bonnier et al. 2010). Data pre-processing included baseline correction, 
smoothing, vector normalisation, and substrate removal. All spectra, including substrate 
backgrounds, were vector normalised and smoothed using a Savitzky–Golay smoothing method 
(order 3, 17 point window). A rubber band correction for baseline removal for all the spectra was 
carried out and the substrate spectra were subtracted from each spectrum. 
Data analysis 
The Raman spectral features were analysed by comparing the mean Raman spectra of HCV 
infected blood plasma samples with healthy ones. The Raman peak assignments were taken from 
the literature, as detailed in Table 2. PCA was used to differentiate groups of the spectral data 
acquired for the different blood plasma samples determined by PCR to be positive for HCV 
infection, and to identify their characteristic spectroscopic signatures. PCA is a mathematical 
procedure involving the transformation of possibly correlated variables into a smaller number of 
uncorrelated variables, known as principal components (PC), basically to reduce the 
dimensionality of the data whilst maintaining their variability. The first principal component 
accounts for the dominant source of variability in the data, and each successive principal 
component accounts for the next highest source of the remaining variability. The loadings of the 
PC can be understood as the orthogonal dimensions of biochemical differences which facilitate 
separation of different groups of spectra of Raman data along their variability as each spectrum 
scores along these dimensions. 
Sample name Viral load value Category  
HCV-1 20,718 Low 
HCV-2 120,533 Low 
HCV-3 132,152 Low 
HCV-4 189,531 Low 
HCV-5 387,823 Medium 
HCV-6 410,358 Medium 
HCV-7 442,365 Medium 
HCV-8 846,668 High 
HCV-9 873,417 High 
HCV-10 907,874 High 
HCV-11 1,718,359 High 
 
Table 1: Viral load values of the HCV samples. 
 
Wave numbers (cm-1) Peak assignments References 
616 C-C twisting (protein)  (Chan, 
Taylor et al. 
2006) 
630 n(C-S) gauche (aminoacid 
methionine)  
(Shetty, 
Kendall et 
al. 2006) 
651 n(C-S) gauche (aminoacid 
methionine)  
(Shetty, 
Kendall et 
al. 2006) 
674 Ring breathing modes in the DNA 
bases G/T 
(Chan, 
Taylor et al. 
2006) 
703 Cholesterol, cholesterol ester  (Krafft, 
Neudert et 
al. 2005) 
720 Adenine (Jess, Smith 
et al. 2007) 
727 Adenine base/DNA   (Kline and 
Treado 
1997) 
751 Symmetric breathing of tryptophan 
(protein assignment) 
 
(Stone, 
Kendall et 
al. 2002; 
Huang, 
McWilliams 
et al. 2003; 
Cheng, Liu 
et al. 2005) 
761 Tryptophan, d (ring)  (Shetty, 
Kendall et 
al. 2006) 
737-73 Lactic acid , DNA, Tryptophan, d 
(ring)  
(Binoy, 
Abraham et 
al. 2004; 
Shetty, 
Kendall et 
al. 2006) 
785/788 Phosphodiester bands in DNA/RNA (Notingher, 
Green et al. 
2004) 
810/815 Proline, hydroxyproline, tyrosine, 
RNA 
(Cheng, Liu 
et al. 2005) 
830 Proline (Cheng, Liu 
et al. 2005) 
850 Most probably due to single bond 
stretching 
vibrations for the amino acids and 
valine and 
polysaccharides 
(Cheng, Liu 
et al. 2005) 
857 Tyrosine, collagen  (Stone, 
Kendall et 
al. 2004) 
880 Tryptophan, d(ring)  (Shetty, 
Kendall et 
al. 2006) 
900 Monosaccharides (b-glucose), (C-O-
C) skeletal 
Mode 
(Shetty, 
Kendall et 
al. 2006) 
911 Glucose  (Krafft, 
Neudert et 
al. 2005) 
922 Collagen  (Frank, 
McCreery et 
al. 1995) 
934 C-C stretching/protein assignment (Stone, 
Kendall et 
al. 2004) 
951 ns(CH3) of proteins  (Lakshmi, 
Kartha et al. 
2002) 
958 Hydroxyapatite, carotenoid, 
cholesterol  
(Stone, 
Kendall et 
al. 2004) 
991 C-O ribose, C-C  (Dukor 
2002) 
1005 Phenylalanine, C-C skeletal (Su, Ho et 
al. 2006) 
1031 d(C-H), phenylalanine (protein 
assignment)  
(Huang, 
McWilliams 
et al. 2003) 
1045 (symmetric stretching vibration of 
PO4 
(Cheng, Liu 
et al. 2005) 
1059 Lipids  (Dukor 
2002) 
1077 PO2 RNA (Huang, 
McWilliams 
et al. 2003) 
1089 Phospholipids  (Huang, 
McWilliams 
et al. 2003) 
1157 In-plane vibrations of the conjugated 
C=C-C 
(Puppels, 
Garritsen et 
al. 1993) 
1175 C-H bending, tyrosine (Ruiz‐Chica
, Medina et 
al. 2004) 
1200-50 Amide III (proteins) (Notingher, 
Green et al. 
2004) 
1214 Stretching of C-N  (Naumann 
1998) 
1222 (PO2), nucleic acids  (Huang, 
McWilliams 
et al. 2003) 
1311-1361 CH3CH2 wagging mode of collagen  (Stone, 
Kendall et 
al. 2004) 
1319 Guanine (Ruiz‐Chica
, Medina et 
al. 2004) 
1322 CH3CH2 twisting (Huang, 
McWilliams 
et al. 2003) 
1344 CH stretching (Farquharso
n, Shende et 
al. 2005) 
1355 Guanine  (Ruiz‐Chica
, Medina et 
al. 2004) 
1390 CH rocking  (Schulz and 
Baranska 
2007) 
1424 Deoxyribose (Ruiz‐Chica
, Medina et 
al. 2004) 
1440 CH2 and CH3 deformation vibrations  (Hanlon, 
Manoharan 
et al. 2000) 
1465 Lipids  (Lakshmi, 
Kartha et al. 
2002) 
1481-1562 Amide II  
 
(Dukor 
2002) 
1484 G, A (ring breathing modes in the 
DNA bases)  
(Chan, 
Taylor et al. 
2006) 
1489 DNA (Malini, 
Venkatakris
hna et al. 
2006) 
1502 C=C stretching in benzenoid ring (Naumann 
1998) 
1522 C=C- carotenoid  (Stone, 
Kendall et 
al. 2004) 
1537 Amide carbonyl group vibrations 
 
(Wood, 
Quinn et al. 
1998) 
1578 Guanine (N3) (Ruiz‐Chica
, Medina et 
al. 2004) 
1602 Amide I band of proteins (Sigurdsson, 
Philipsen et 
al. 2004; 
Chan, 
Taylor et al. 
2006) 
1620 n(C=C), tryptophan (protein 
assignment)   
(Huang, 
McWilliams 
et al. 2003) 
1641 Amide I (alpha-helix)  (Stone, 
Kendall et 
al. 2004) 
1676 Amide I (beta-sheet)  (Lakshmi, 
Kartha et al. 
2002). 
1678 C=O stretching mode of dGTP of 
RNA 
(D'Amico, 
Cammisuli 
et al. 2015) 
1708 n(C=O)OH (amino acids aspartic & 
glutamic 
acid) 
(Shetty, 
Kendall et 
al. 2006) 
1721 C=O stretching/proteins (Movasaghi, 
Rehman et 
  
 
 
 
 
 
 
 
 
 
 
Table 2: Peak assignments of the Raman spectral features. 
 
Results: 
Figure 1 shows the mean Raman spectra of samples of healthy (a) and HCV positive blood 
plasma samples with low (b), medium (c) and high (d) viral load values. The Raman spectral 
features present in mean Raman spectra of blood plasma samples of healthy individuals (a) 
include those assigned to proteins, at 651 cm-1(C-S stretching of amino acid), 674 cm-1(C-S 
stretching), 727 cm-1(C-C stretching), 737-773 cm-1(C-S stretching, tryptophan), 1311-1361 cm-1 
(amide, tryptophan), 880 cm-1(tryptophan ring), 934 cm-1(C-C backbone of proteins /alpha helix 
stretching), 1175cm-1(C-H bending, tyrosine), 1481-1562 cm-1(Amide II), 1602 cm-
1(phenylalanine), 1641 cm-1(amide-I). Moreover, other Raman features present in healthy spectra 
can be assigned to lipids, including those at 958 cm-1 (C-C stretching of lipids), 1059 cm-1 (C-C 
al. 2007) 
1729 Ester group (Krafft, 
Neudert et 
al. 2005) 
1738 Lipids  (Dukor 
2002) 
1749 C=O stretching (Malini, 
Venkatakris
hna et al. 
2006) 
1765 C=O sym stretch; part of doublet (Schrader 
2008) 
1778 C=O stretch (Schrader 
2008) 
1783 C=O stretch (Schrader 
2008) 
str./lipids), 1390 (C-N rocking), 1620 cm-1 (C-C stretching), 1729 cm-1 (ester group) and 1738 
cm-1 (C=O of ester group in lipids). Notably, no Raman features associated with DNA/RNA are 
evident in the healthy blood plasma samples. 
To highlight the changes in the mean Raman spectra of HCV positive samples, he peak 
assignments have been labelled in Figures 1 (b-c) with; red boxes for prominent and striking 
differences in different viral load values, rectangles for intensity changes and vertical lines for 
other differences. 
The peak intensities of the above mentioned protein and lipids related peaks are increasing in (b), 
(c) and (d) with increase in degree of infection. Now, the most striking differences, observed in 
the mean Raman spectra, are the Raman spectral features which are solely observed for the HCV 
positive samples including those at 720 cm-1 (adenine), 1077 cm-1 (PO2 stretching of RNA), 1678 
cm-1(C=O stretching mode of dGTP of RNA), 1778 cm-1 (RNA), 1641 (amide-I), 1721 cm-
1(C=C stretching of proteins)and 1738 cm-1 (C=O of ester group in lipids). These Raman features 
are potentially spectral markers for the presence of infection of HCV in the blood plasma 
samples. 
c 
Figure 1:Mean Raman spectra of healthy and HCV positive blood plasma samples with 
increasing viral load values; healthy (a), low viral load (b), medium viral load (c) and high viral 
load (d) as described in Table 1.(Vertical lines with red box are for striking differences ,without 
red box are showing intensity changes and doted box for bands and pattern change). 
 
In Figure 2, mean difference spectra, healthy minus HCV positive blood plasma samples, of 
different viral load values which, for the purpose of comparison (Table-1), are divided into three 
classes including low (a), medium (b) and high (c), are shown. In the mean difference spectra, 
the differences in Raman spectral features associated with 3 different ranges of infection levels 
of HCV have been observed, and labeled. The difference spectra confirm the observations of 
Figure 1,as the Raman spectral features which feature prominently in the HCV positive samples,  
including those at720 cm-1 (adenine), and 1077 cm-1 (PO2 stretching of RNA), 1678 C=O 
stretching mode of dGTP of RNA, 1778 cm-1 (RNA), 1641 (amide-I), 1721 cm-1(C=C stretching 
of proteins)and 1738 cm-1 (C=O of ester group in lipids), appear only in the HCV positive 
samples and hence maybe attributable to RNA stretching of the hepatitis C virus itself. These 
spectral features can be considered as direct markers of the viral infection in addition to those 
which are associated with the development of the biochemical changes during HCV infection. 
Clear differences in peak intensities at 616 (C-C twisting of proteins), 630 (C-S of amino acid 
methionine), 751 (symmetric breathing of tryptophan), 857 (Tyrosine), 951 (CH stretching of 
protein alpha-helix), 1031, 1045, 1214 (stretching of C-N), 1440 (CH2 and CH3 deformation), 
1465 (CH stretching of lipids), 1484 (G, A/RNA bases), 1522 (C=C- carotenoid), 1708 and 1765 
(C=O of amino acids), and 1783 cm-1 are observed. These differences indicate the progression of 
the HCV infection from low to medium and high viral loads 
 
Figure 2: Mean difference Raman spectra of three classes of HCV samples including low (a), 
medium (b) and high (c) viral loads as described in Table-1. Spectra are off-set for clarity. 
 
 Figure 3 PCA scatter plots of Raman spectral data of different categories of HCV samples 
according to viral load values including low versus medium (a), medium versus high (b) and 
their respective PCA loadings.  
 
In Figure 3 (a, b and c) PCA scatter plots and loadings of Raman spectral data of different 
categories of HCV samples according to viral load values including low (HCV-2), medium 
(HCV-5 and HCV-7) and high (HCV-11), as detailed in Table-1, are presented. The separation 
between the Raman spectra of HCV confirmed blood plasma samples of different categories of 
HCV samples according to viral load values is observed along PC-1.The Raman spectral features 
which are on the positive side are associated with low to high viral loads. In this regard, those 
Raman spectral features which have higher intensities with the severity of disease include those 
at720 cm-1 (adenine), 1077 cm-1 (PO2 stretching of RNA), 1678 C=O stretching mode of dGTP 
of RNA, 1778 cm-1 (RNA), 1641 (amide-I), 1721 cm-1(C=C stretching of proteins)and 1738 cm-1 
(C=O of ester group in lipids. 
 
Principal components analysis (PCA) was performed on the Raman spectral data of the ten 
controls/ healthy and eleven confirmed HCV samples, having different viral load values. In the 
PCA scatter plot, Figure 4 (a), the blue and red dots represent Raman spectra of HCV positive 
and healthy blood plasma samples, respectively, which are largely clustered on the positive and 
negative sides of PC-1 respectively, which accounts for 79% of the variance, while PC-2 
accounts for only 7 %. The differentiation between these two different groups of Raman spectra 
supports the proposal that Raman spectroscopy has great potential to differentiate the blood 
plasma samples of the healthy and HCV positive individuals on the basis of the biochemical 
changes with reference to their viral load values of HCV.  
To understand the basis of the discrimination in the PCA scatter plot, the loadings of PC-1 are 
presented in Figure 4 (b).The positive loadings (positive side from separating line at zero) are 
associated with the Raman spectral data of the HCV positive samples while the negative loadings 
are associated with the healthy samples. Notably, (in Figure 4) the PCA loadings including those 
at 674 cm-1, associated with the T/G of RNA,720 cm-1 (adenine) and 1077 cm-1 (PO2 stretching 
of RNA),1678 cm-1 C=O stretching mode of dGTP of RNA, 1778 cm-1 (RNA), 1641 (amide-I), 
1721 cm-1(C=C stretching of proteins)and 1738 cm-1 (C=O of ester group in lipids) are associated 
with the HCV positive samples. These observations once again confirm the results explained in 
the previous Figures and prove the ability of the Raman spectroscopy to identify the biochemical 
changes taking place during HCV infection. The observation of these Raman features as positive 
loadings indicate their association with the HCV RNA hence to the development of the HCV 
infection due to increasing viral load. Moreover, some other Raman spectral features/changes are 
also observed with a reduction in the their peak intensity or are not present in the control/healthy 
samples and are well developed in positive blood plasma samples indicated by the wave numbers 
including 880cm-1( associated with tryptophan), 1089cm-1 (C-C stretching), 1390cm-1 (C-N 
rocking), 1502cm-1(cytosine),1641cm-1(Amide-I),1728cm-1 (ester) and 1738cm-
1(lipids)(Movasaghi, Rehman et al. 2007). Furthermore, in comparison of loading with 
experimental Raman spectrum of pure RNA some peaks are observed which are similar in 
loadings of HCV samples including 720cm-1, 813cm-1, 880cm-1, 922cm-1, 1105cm-1, 1489cm-1, 
and 1578cm-1. These Raman spectral features observed in the Figure 4indicate that all these 
biochemical changes/Raman spectral features can be considered as markers of HCV infection as 
they are also present in experimental Raman spectra of pure RNA and absent in the 
healthy/control Raman spectra. 
 
Figure 4 PCA scatter plot (a) and loadings of Raman spectral data acquired from healthy versus 
confirm HCV samples (b). 
 
 
 
Conclusions 
In order to identify the biochemical changes occurring during the process of Hepatitis C 
development, Raman spectroscopy along with Principal Component analysis is employed. 
Raman spectral features as indicated by Principal Component analysis are hence established 
which can be associated with the human blood plasma samples of the infected and healthy 
individuals. Among others, the Raman spectral features which are observed only for the HCV 
positive samples include 720 cm-1 (adenine), 1077 cm-1 (PO2 stretching of RNA), 1678 C=O 
stretching mode of dGTP of RNA, 1778 cm-1 (RNA), 1641 (amide-I), 1721 cm-1(C=C stretching 
of proteins)and 1738 cm-1 (C=O of ester group in lipids). These differences in Raman spectral 
features of blood plasma samples of the patients and healthy volunteers can be associated with 
the development of the biochemical changes during HCV infection. 
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